MK-677 and Teriparatide Interaction

Synergistic
Mechanism-based 47% confidence

MK-677 and Teriparatide have a synergistic interaction with 47% confidence. MK-677 and Teriparatide work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Teriparatide

PTH(1-34) | Bone-Building Anabolic Peptide

Teriparatide binds to PTH type 1 receptors (G-protein coupled receptors) on osteoblasts, osteocytes, and renal tubular cells. This activates PKA and PKC signaling pathways that promote osteoblast activity.

Half-life: ~1 hour (subcutaneous); ~5 minutes (intravenous) Typical dose: 20mcg daily (FDA-approved dose) healing
igf1pth receptor teratogenic
View full profile

Combined Organ Load

Brain
low
GI Tract
low
Pituitary
low
Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (MK-677, Teriparatide). Monitor accordingly.

Frequently Asked Questions

Can I take MK-677 with Teriparatide?

Yes, MK-677 and Teriparatide can generally be taken together. MK-677 and Teriparatide work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is MK-677 and Teriparatide safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between MK-677 and Teriparatide?

MK-677 and Teriparatide work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time MK-677 and Teriparatide?

MK-677 has a half-life of ~24 hours and Teriparatide has a half-life of ~1 hour (subcutaneous); ~5 minutes (intravenous). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: MK-677 vs Teriparatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.